Nanovaccines in Cancer Immunotherapy: Lymph Node-Targeted Strategies and Mechanistic Insights
Nanovaccine platforms can potentially overcome some constraints of conventional vaccines by enhancing lymph node targeting, antigen stability, and immunogenicity. Further research in this field could further advance targeted cancer immunotherapy.
Authors
- Kamal Shah (ORCID: https://orcid.org/0000-0003-2389-0563)
- Hitesh Kumar Dewangan (ORCID: https://orcid.org/0000-0003-3440-1884)
- Ramajay Gupta
- Rajni
Institutions
- Chandigarh University (IN)
- DAV University (IN)
- Indian Institute of Technology BHU (IN)
- GLA University (IN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2026-02-25
- DOI
- https://doi.org/10.2174/0113816128384257251211183939
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00